Search clinical trials for: Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)

Total 2367 results

Bayer
Janssen Research & Development, LLC

Completed

Xarelto Regulatory Post-Marketing Surveillance

Venous Thromboembolism

Korea, Republic of
Juan A. Arnaiz

Unknown

Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine (RALAM)

AIDS

Spain
Lehigh Valley Hospital
GlaxoSmithKline

Terminated

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients (BRiEF)

Venous Thrombosis

United States
GlaxoSmithKline

Completed

Hemorrhage Risk Prescribed Arixtra

Thrombosis, Venous
Sanofi

Completed

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Pulmonary Embolism

United Kingdom, United States, Canada, Argentina, Austria, Norway, Czech Republic, Denmark, France, Australia, Belgium, Brazil, Finland, Germany, Italy, Netherlands, Poland, Spain, Sweden, Switzerland
Dr.Vandana Bansal

Unknown

Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come

India
GlaxoSmithKline

Completed

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (FUTURA/OASIS 8)

Acute Coronary Syndrome

Canada, France, Bulgaria, Germany, Poland, United Kingdom, Spain, Russian Federation, Korea, Republic of, Netherlands, India, United States, Brazil, Hungary, Italy, Argentina, Czech Republic, Greece
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Ain Shams University

Not yet recruiting

Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss

Recurrent Pregnancy Loss
GlaxoSmithKline
Sanofi

Completed

OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction

Thromboembolism
Pfizer

Active, not recruiting

Anticoagulation in Patients With Venous Thromboembolism and Cancer (VICTORIE)

Neoplasms | Embolism

United Kingdom
GlaxoSmithKline

Completed

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Thrombosis, Venous

Japan
University of Turku
Oulu University Hospital; Tampere University Hospital; Satakunta Central Hospital

Completed

Anticoagulant Therapy During Pacemaker Implantation (FINPAC)

Hemorrhage | Embolism | Thrombosis

Finland
GlaxoSmithKline

Completed

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism (FondaPPP)

Thromboembolism | Venous Thromboembolism

Germany
GlaxoSmithKline

Completed

Fondaparinux EU-RMP (Adherence)

Acute Coronary Syndrome
Università degli Studi dell'Insubria

Terminated

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency

Renal Insufficiency | Medical Patients

Italy
Berlin-Chemie AG Menarini Group

Completed

Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT

Deep Vein Thrombosis

Georgia, Russian Federation
Duke University
GlaxoSmithKline

Withdrawn

Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

Kidney Diseases

United States
Indiana University School of Medicine
American Society for Bariatric Surgery

Withdrawn

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Morbid Obesity

United States
HaEmek Medical Center, Israel

Completed

anti10a Levels in Women Treated With LMWH in the Postpartum Period

Venous Thromboembolism

Israel
NYU Langone Health
GlaxoSmithKline

Withdrawn

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Ovarian Carcinoma

United States
G. d'Annunzio University

Completed

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Unsuspected Pulmonary Embolism

Spain, France, Netherlands, Italy, United States, Austria, Canada, Germany
GlaxoSmithKline

Completed

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)

Cardiovascular Disease
University of Pittsburgh
GlaxoSmithKline

Completed

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

Venous Thrombosis | Pulmonary Embolism

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

Cardiovascular Disease
GlaxoSmithKline

Completed

Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

Venous Thromboembolism

Japan
Paul Di Cesare,MD

Completed

The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

Total Knee Replacement

United States
GlaxoSmithKline
Sanofi

Completed

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Thromboembolism
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline

Completed

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. (PROPICE)

Major Orthopaedic Surgery and Renal Impairment

France
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis

Thrombophlebitis

Italy
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Terminated

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy (P1094)

HIV Disease

United States, Puerto Rico, Argentina, Brazil, Thailand
University of Louisville
James Graham Brown Cancer Center

Terminated

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Heparin-Induced Thrombocytopenia

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

Ataxia
GlaxoSmithKline

Completed

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Thrombosis, Venous

Netherlands, Spain, Germany, Italy, Poland, Russian Federation, France, Israel, Estonia, Hungary, Slovakia, Latvia, Greece, Ukraine, Czech Republic, Switzerland, Bulgaria
Suzanne C. Cannegieter, MD PhD
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation (Pot-Cast)

Pulmonary Embolism | Deep Venous Thrombosis

Netherlands
EDDC (Experimental Drug Development Centre), A*STAR...
Chiltern International Inc.

Withdrawn

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) | Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)

United States, Singapore
GlaxoSmithKline

Completed

Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment

Ataxia
The New England Baptist Hospital

Unknown

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery (DVT)

Pulmonary Embolism

United States
Sherief Abd-Elsalam

Unknown

Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.

HCC

Egypt
Melbourne Health

Terminated

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.

Renal Failure

Australia
Duke University
GlaxoSmithKline

Completed

"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" (FONDA PK)

Renal Insufficiency

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Multiple Myeloma and Plasma Cell Neoplasm

United States
Aswan University Hospital

Unknown

Aspirin for Prevention of Preeclampsia

Preeclampsia

Egypt
Masonic Cancer Center, University of Minnesota

Completed

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Thromboembolism | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

Hypercholesterolemia

Japan
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery (FONDACAST)

Thrombosis, Venous

Spain, Germany, Russian Federation, France, Italy, Netherlands
Wayne State University
GlaxoSmithKline

Unknown

Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication

ICU Patients 18 Years or Older.

United States
Suzanne C. Cannegieter, MD PhD
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy (Pot-Kast)

Pulmonary Embolism | Deep Venous Thrombosis

Netherlands
Huazhong University of Science and Technology

Completed

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Venous Thromboembolism | Gynecologic Neoplasms | Low Molecular Weight Heparin | Argatroban

China
Mary Knudson, M.D.
GlaxoSmithKline

Completed

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients

Venous Thromboembolism

United States

Search clinical trials for: Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations